US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Editas Medicine Inc (0IFK) 銘柄情報

Editas Medicine Inc (0IFK)

33.38

0.00

(0.00%)

終了 7月6日 12:30AM

Editas Medicine Inc (0IFK) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

33.38

( - )

買値

33.38

売値

33.38

出来高

0.00

0.00 日の範囲 0.00

33.38 52 週間の範囲 33.38

時価総額

前日終値

33.38

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 2,340,464

発行済株式数

153,461,838

配当利回り

PER

-2.78

1 株当たり利益 (EPS)

-1.18

歳入

38.69M

純利益

-108.95M

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed ... Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalassemia; and in vivo gene editing medicines indicated for other cells and tissues. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors, and autoimmune disease. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.editasmedicine.com

本社

Cambridge, United States

設立

2026

Editas Medicine Inc is listed in the sector of the ロンドン証券取引所 with ticker 0IFK. The last closing price for Editas Medicine was US$33.38. Over the last year, Editas Medicine shares have traded in a share price range of US$ 33.38 to US$ 33.38.

Editas Medicine currently has 153,461,838 shares in issue. The market capitalisation of Editas Medicine is US$5.12 billion. Editas Medicine has a price to earnings ratio (PE ratio) of -2.78.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	33.38	33.38	33.38	12251	33.38	DE
52	0	0	33.38	33.38	33.38	16852	33.38	DE
156	0	0	33.38	33.38	33.38	14329	33.38	DE
260	0	0	33.38	33.38	33.38	8811	33.38	DE

0IFK - Frequently Asked Questions (FAQ)

What is the current Editas Medicine Inc share price?

The current share price of Editas Medicine Inc is US$ 33.38

How many Editas Medicine Inc shares are in issue?

Editas Medicine Inc has 153,461,838 shares in issue

What is the market cap of Editas Medicine Inc?

The market capitalisation of Editas Medicine Inc is USD 5.12B

What is the 1 year trading range for Editas Medicine Inc share price?

Editas Medicine Inc has traded in the range of US$ 33.38 to US$ 33.38 during the past year

What is the PE ratio of Editas Medicine Inc?

The price to earnings ratio of Editas Medicine Inc is -2.78

What is the cash to sales ratio of Editas Medicine Inc?

The cash to sales ratio of Editas Medicine Inc is 13.01

What is the registered address of Editas Medicine Inc?

The registered address for Editas Medicine Inc is 11 Hurley Street, Cambridge, Massachusetts, 02141

What is the Editas Medicine Inc website address?

The website address for Editas Medicine Inc is www.editasmedicine.com

rogers711

rogers711 7分前

Says the one that has held a penny stock for years and made 0 👍😂 congrats! Imagine what you could have done with the money tied up here doing nothing… many permabulls here have tied up massive liquidity in a micro penny stock and think they are great investors…

stockrafter

stockrafter 7分前

It is obvious from all the patent filings for drugs, and fancy new injectors they are setting Halozyme to produce a number of internal Drug-concentration-enhanze/AI combos......Do doubt about it.....could easily make a list of few......On the way to $100 and beyond. AR

CatfishHunter

CatfishHunter 10分前

I doubt you will, but if so, best of luck flipping $50 for a 25%-45% gain.

Eths

SNTX
https://x.com/ethsbythelake/status/2073898723017470310?s=46&t=6Y7w8L7iBETCgMYpIXWuzg

3331

Math concludes BIEL will be the GOAT!
BIEL hitting PPS .10 puts it in the conversation for the greatest stock ever - more than 100,000% appreciation from their all-time low.

Two companies currently compete for the absolute top spot in modern history: Apple and former penny sto

Frank69OH

Frank69OH 15分前

Hey_Its_That_Guy

Hey_Its_That_Guy 16分前

I don't see those numbers on my Schwab. But stuff like that does happen. Hopefully we'll have a good week

Legend431

Legend431 16分前

Doc - I’m not paid here despite all the posts. Nothing is going to happen. Hope you had a great 4th

santafe2

santafe2 17分前

Quiet Sunday night so I'm working through a few ideas. Comments pro or con always welcome. This is a complex, short term, economic period.

We have the birth of the AI age which will alter economies as much or more than any previous technical revolution. That's the long term change. I

Telefon

Telefon 23分前

What would be involved in removing the Rat as CEO? Would it need to be initiated by the board of directors? Could shareholders hold a meeting and demand his removal?

rogers711

rogers711 23分前

Planning to buy this week after panic selling just like last time and buy in the .029-.036 range for a quick bounce back to .05 where it will sit for another year. All in my opinion…

S-BEES-BUMBLEBEE

S-BEES-BUMBLEBEE 23分前

Great! A massive jump in the share price is very possible here. $GDC $BTC

monentum2play

monentum2play 24分前

Everyone knows what a scammer he is, Nobody listens to him and not worth mentioning his name

Guido2

Guido2 25分前

Decision Makers are on X. Shareholders should go to X to like and repost all posts criticizing the conservatorship. This board is a good place to share such posts.

3 and out.

misterfishman

misterfishman 25分前

Well,that was grim.keep hope alive fir all of us preacher.

long_haul

long_haul 27分前

Those targets are just based on the technicals or are you baking in some fundamental news in there too?

JusDePomme

JusDePomme 28分前

What happen if if Mexico loose?????will biei exploded this week???😁

long_haul

long_haul 29分前

Well they have a standstill agreement with the note holders so for certain no conversions until July 24. And they will likely settle with those note holders during that time.

Things are looking solid right now. Only question is what big news will be next

MasterBlastr

MasterBlastr 30分前

Nice work all the Gotterup pickers. Good to see Glover and Homa near the top for a change. Now for a real change of venue. Will be interested to see how Gotterup plays across the pond.

Large Green

Large Green 31分前

If 9/13/2026 is the drop-dead date, then one has to plan for issues to arise plus time to handle which to me means the distributions would need to be finished by say August 13 or so. This means we would have to know about them well before deadline.

OMOLIVES

OMOLIVES 35分前

Exactly. That is the point. It's only five thousand dollars. How can they pay $250,000 for an option but can't seem to find FIVE THOUSAND DOLLARS before they even amended the agreement....or since then. And why would they need three Months in order to cover it...lol.

Truenorth2016

Truenorth2016 35分前

Canada Got Blown Out But Hey, We Still Got U.S And Mexico....Of Course I want U.S To Go All The Way!!! However, Watching Mexico and England right now. BIEI Need to Capatalize off of all this hype Mexico keeps getting from their wins!!

peafunke

peafunke 35分前

“ They must see something that none of us has had access to yet”
I believe they do. But just not with the app or backend in its current state. Let’s gooooooooo

stockanalyze

stockanalyze 37分前

honestly, our posts are having zero effect over 19 yrs. it is sad but true. people who are decision makers aren't here. but we still keep howling and get some satisfaction that we did our part.

Editas Medicine

Purpose Best Ideas

Bmo Selecttrust Conserva...

Boerse Stuttgart Commodi...

Uncles Ice Cream (PK)

State Street SPDR JP Mor...

FTSE Transatlantic Aeros...

BNP Paribas Issuance

PT Lippo Karawaci TBK (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。